It has been an incredibly busy and exciting year for our Strategy & Business Transformation practice at Kaufman Hall. In 2024, we observed hospitals and health systems take steps to reinvigorate their strategic efforts amid a stabilizing, but still challenging, outlook.

The future will favor payers that adapt to changing market circumstances with agency and velocity. Payers will need to make tough choices.

With extension of the 2017 tax cuts identified as a key priority for the incoming Trump administration, offsetting expense actions will be needed to avoid increasing the federal deficit. Hospital leaders should be prepared for potential cuts to both the Medicaid program and the enhanced ACA subsidies enacted in 2021.

As hospitals and health systems intensify their financial planning efforts, revisiting and refining the forecasting techniques and tools that guide their decisions has become paramount.

Carol Skenes, Interim Vice President of Product at Turquoise, joins host J. Carlisle Larsen to talk about what their researchers found after reviewing industry-wide data.

CMS proposes adding weight-loss drugs to Medicare coverage, Trump nominates more healthcare positions, and a study tracks widespread pharmacy closures.

Following the release of Q3 financial reports, this week’s graphic takes stock of large health insurance companies’ recent financial performances.

This month’s data show general stability, with continued growth in outpatient revenue and expense reductions on a volume-adjusted basis.

A growth strategy focused on access, accretive opportunities, and ambulatory represents a new “Triple A” for hospitals and health systems.

On this week’s Monday interview, host J. Carlisle Larsen speaks with Kaufman Hall’s Scott Christensen about trends within the retail healthcare delivery space and what hospitals can learn from these organizations’ stumbles and successes.

In 2021, Carilion Clinic, a $2 billion revenue, eight-hospital integrated system in Roanoke, Virginia, was facing a problem familiar to many systems around the country: stubbornly high...

Trump picks his healthcare cabinet nominees, PBMs sue the FTC over its insulin case, and controlled substance telehealth flexibilities are extended yet again.